204 related articles for article (PubMed ID: 25070346)
1. The effectiveness of riboflavin photochemical-mediated virus inactivation and changes in protein retention in fresh-frozen plasma treated using a flow-based treatment device.
Zhu L; Pan J; Wei C; Wang H; Xiang R; Zhang J; Wang D
Transfusion; 2015 Jan; 55(1):100-7. PubMed ID: 25070346
[TBL] [Abstract][Full Text] [Related]
2. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
Smith J; Rock G
Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
[TBL] [Abstract][Full Text] [Related]
3. Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.
Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP
Transfus Apher Sci; 2011 Feb; 44(1):25-31. PubMed ID: 21251884
[TBL] [Abstract][Full Text] [Related]
4. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
Ruane PH; Edrich R; Gampp D; Keil SD; Leonard RL; Goodrich RP
Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
[TBL] [Abstract][Full Text] [Related]
5. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP
Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
[TBL] [Abstract][Full Text] [Related]
6. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.
Keil SD; Bengrine A; Bowen R; Marschner S; Hovenga N; Rouse L; Gilmour D; Duverlie G; Goodrich RP
Transfusion; 2015 Jul; 55(7):1736-44. PubMed ID: 25731607
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment.
Keil SD; Bowen R; Marschner S
Transfusion; 2016 Dec; 56(12):2948-2952. PubMed ID: 27805261
[TBL] [Abstract][Full Text] [Related]
9. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
Balint B; Jovicic-Gojkov D; Todorovic-Balint M; Subota V; Pavlovic M; Goodrich R
Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430
[TBL] [Abstract][Full Text] [Related]
10. [Pathogen inactivation in fresh frozen plasma using riboflavin and ultraviolet light: effects on plasma proteins and coagulation factor VII].
Stanojković Z; Antić A
Vojnosanit Pregl; 2011 Jan; 68(1):51-6. PubMed ID: 21425619
[TBL] [Abstract][Full Text] [Related]
11. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.
Hornsey VS; Drummond O; Morrison A; McMillan L; MacGregor IR; Prowse CV
Transfusion; 2009 Oct; 49(10):2167-72. PubMed ID: 19555414
[TBL] [Abstract][Full Text] [Related]
12. Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.
Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP
Transfus Apher Sci; 2012 Feb; 46(1):15-8. PubMed ID: 22115607
[TBL] [Abstract][Full Text] [Related]
13. Development of a riboflavin and ultraviolet light-based device to treat whole blood.
Reddy HL; Doane SK; Keil SD; Marschner S; Goodrich RP
Transfusion; 2013 Jan; 53 Suppl 1():131S-136S. PubMed ID: 23301965
[TBL] [Abstract][Full Text] [Related]
14. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
[TBL] [Abstract][Full Text] [Related]
15. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Bu D; Bhakta V; Sheffield WP; Goodrich RP; Devine DV
Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
[TBL] [Abstract][Full Text] [Related]
16. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
[TBL] [Abstract][Full Text] [Related]
17. Riboflavin and ultraviolet light: impact on dengue virus infectivity.
Faddy HM; Fryk JJ; Watterson D; Young PR; Modhiran N; Muller DA; Keil SD; Goodrich RP; Marks DC
Vox Sang; 2016 Oct; 111(3):235-241. PubMed ID: 27281512
[TBL] [Abstract][Full Text] [Related]
18. Quantitative and qualitative analysis of proteins in fresh frozen plasma obtained from whole blood donations and prepared with two photochemical treatments.
Cid J; Ramiro L; Martínez N; Palomo M; Magallon O; Claparols M; Ortiz P; Puig L; Pla RP
Transfus Apher Sci; 2008 Oct; 39(2):115-21. PubMed ID: 18710822
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
Keil SD; Ragan I; Yonemura S; Hartson L; Dart NK; Bowen R
Vox Sang; 2020 Aug; 115(6):495-501. PubMed ID: 32311760
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of dengue virus in plasma with amotosalen and ultraviolet A illumination.
Musso D; Richard V; Broult J; Cao-Lormeau VM
Transfusion; 2014 Nov; 54(11):2924-30. PubMed ID: 24845685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
